BRIEF published on 04/24/2026 at 07:05, 3 months 18 days ago BB Biotech AG publie ses résultats intermédiaires du premier trimestre 2026 Perte Nette Portefeuille D'investissement Développement De Médicaments BB Biotech 1er Trimestre 2026
BRIEF published on 04/24/2026 at 07:05, 3 months 18 days ago Réalisations et évolutions stratégiques de BB Biotech au premier trimestre 2026 Valeur Nette D'actif Nouveaux Investissements Performance De BB Biotech Repositionnement De Portefeuille Inclusion De Dividendes
BRIEF published on 04/24/2026 at 07:05, 3 months 18 days ago BB Biotech Q1 2026 Achievements and Strategic Shifts Net Asset Value Portfolio Repositioning New Investments BB Biotech Performance Dividend Inclusion
PRESS RELEASE published on 04/24/2026 at 07:00, 3 months 18 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first quarter of 2026, showing a net loss of CHF 21 mn compared to CHF 241 mn in the same period of 2025 Investment Company BB Biotech AG Interim Report Results Loss
PRESS RELEASE published on 04/24/2026 at 07:00, 3 months 18 days ago BB Biotech Q1 2026: Share price outperformance, narrowing discount and active portfolio repositioning BB Biotech AG reports Q1 2026 results with share price outperformance, narrowing discount, and active portfolio repositioning. Eleven new investments made in biotech sector Share Price BB Biotech AG Investments Portfolio Repositioning Q1 2026
BRIEF published on 03/19/2026 at 17:45, 4 months 24 days ago L'assemblée générale annuelle de BB Biotech AG approuve les propositions et le dividende Stratégie D'investissement Assemblée Générale Annuelle Réélection Du Conseil D'administration Approbation Des Dividendes BB Biotech
BRIEF published on 03/19/2026 at 17:45, 4 months 24 days ago BB Biotech AG's AGM Approves Proposals and Dividend Annual General Meeting Investment Strategy Board Re-election Dividend Approval BB Biotech
PRESS RELEASE published on 03/19/2026 at 17:40, 4 months 24 days ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.25 per share Shareholders at BB Biotech AG's AGM approve CHF 2.25 dividend per share. Board proposals endorsed. Re-election of board members Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/20/2026 at 07:05, 5 months 20 days ago BB Biotech AG publie son rapport annuel 2025 Proposition De Dividende Augmentation Du Bénéfice Net BB Biotech Secteur De La Biotechnologie Rapport Annuel 2025
BRIEF published on 02/20/2026 at 07:05, 5 months 20 days ago BB Biotech AG Releases 2025 Annual Report Dividend Proposal Biotechnology Sector Net Profit Increase BB Biotech 2025 Annual Report
Published on 08/12/2026 at 23:30, 7 hours 20 minutes ago CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 7 hours 20 minutes ago Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle
Published on 08/12/2026 at 23:20, 7 hours 30 minutes ago RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/12/2026 at 23:05, 7 hours 45 minutes ago Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend
Published on 08/13/2026 at 06:45, 5 minutes ago PURE Swiss Opportunity REF (PSO) acquires three attractive residential properties and optimizes its portfolio by selling two properties
Published on 08/13/2026 at 06:25, 24 minutes ago Angelaligner Will Appeal Chinese Court Decision about Premolar Extraction Solution, Which Has No Impact on Customers
Published on 08/13/2026 at 02:00, 4 hours 50 minutes ago A New Category Is Emerging in the Premium Residential Market — the 'Presidence'
Published on 08/13/2026 at 01:05, 5 hours 44 minutes ago Pepperstone Appoints New CTO to Drive AI-Native Proprietary Tech Push
Published on 08/11/2026 at 17:45, 1 day 13 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 13 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 12 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 12 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
